Could psychedelic mushrooms be the answer to treating depression?
6PR Mornings with Liam Bartlett, April 13, 2022
Listen to our Executive Director, Tania de Jong AM, discuss the potential in psychedelic medicines on 6PR Mornings with Liam Bartlett.
PharmAla Biotech to supply Mind Medicine Australia with GMP MDMA for Clinical Trial
News Wire, April 8, 2022
PharmAla’s GMP MDMA will accelerate trial work funded by Australia’s premier Psychedelics charity.
Professor David Nutt (UK) Interview on FM104
FM104, April 5, 2022
Mind Medicine Australia Ambassador Professor David Nutt (UK) discusses the current state of psychedelics including the progress with Mind Medicine Australia.
State roadblocks TGA approval of psychedelic-assisted therapies
6PR Mornings, February 10, 2022
Former Chief of Australia’s Defence Force and Mind Medicine Australia board director Professor Admiral (Ret) Chris Barrie AC said Australia’s TGA has given 40 approvals to doctors to provide certain treatments to patients suffering from treatment-resistant PTSD on a case by case basis.
But these approvals are being blocked at the state level.
In Canada, which has a similar health system to Australia, doctors require just one simple approval, which makes access easier.
Mr Barrie says Australia needs to follow suit, with these treatments the only hope for many Veterans suffering PTSD.
‘This is not palliative care; this is curative’: How MDMA could be used to treat depression and PTSD
ABC Mornings, January 18, 2022
Mind Medicine Australia chairman Peter Hunt says clinical trials in the use of psychedelic medicines could be “curative” for people living with mental illnesses.
Quest for new mental illness treatments continues with MDMA and psilocybin trial
Examiner, January 18, 2022
New research looking into the effects of MDMA and psilocybin on the brain is set to take place as part of a continuing push to make psychedelic medicines a mainstream treatment for depression and other mental health disorders
The Power of Psychedelic Assisted Therapies
Crappy to Happy Podcast, January 14, 2022
In this episode of the Crappy to Happy podcast, host Cass Dunn chats with Tania de Jong AM, who is a social entrepreneur, incredibly talented soprano and co-founder of the not-for-profit, Mind Medicine Australia.
Mind Medicine Australia joins global coalition launched to secure a rescheduling of psilocybin under the 1971 UN Convention on Psychotropic Substances
Mind Medicine Australia, January 13, 2022
Today Mind Medicine Australia joins in the launch of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI), a global coalition working to promote and secure a rescheduling of psilocybin under the 1971 Convention on Psychotropic Substances
Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines
Mind Medicine Australia, January 10, 2022
Mind Medicine Australia (MMA) is delighted to announce that it is part-funding a clinical trial which has just received Human Research Ethics approval and is designed to study the brain activity of participants after taking psychedelic medicines.
Find Your Voice: How This Acclaimed Australian Soprano Believes That Together We Can Change The World One Voice At A Time
Finding Genius Podcast, December 24, 2021
Our Executive Director Tania de Jong AM was interviewed in this podcast about her work with mental health charities Creativity Australia and Mind Medicine Australia.
From Investment Banking To Psychedelics: Changing The Treatment Paradigm For Mental Illness With Peter Hunt
Wake the f*** up podcast, December 21, 2021
This podcast is an exploration into Peter Hunt’s journey into spirituality and finding greater connection, meaning and peace which led to the establishment of Mind Medicine Australia with his wife Tania de Jong. It also explains why it is so urgent for psychedelic-assisted therapies to become part of our mental health system and the importance of Governments becoming proactive in this field, rather than reactive. There is so much suffering which could be alleviated through these transformational therapies.
Emyria to expand Real World Data assets for MDMA-assisted therapy trials by incorporating wearables monitoring
Emyria (ASX: EMD ) Press Release, December 20, 2021
Emyria’s phase 2b MDMA-assisted therapy trial for severe Post Traumatic Stress Disorder (PTSD), EMDMA-001, developed with registered charity Mind Medicine Australia (MMA), will be the first program to incorporate Cydelic technology and is expected to be one of the first programs in the world to incorporate remote patient monitoring within MDMA-assisted therapy.
TGA blocks use of MDMA, magic mushrooms trials for mental health
AFR, December 17, 2021
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions
ABC News, December 16, 2021
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
The Wellness Couch Podcast, Episode #92 with Tania de Jong AM
The Wellness Couch Podcast, December 16, 2021
In this podcast, Mind Medicine Australia Executive Director, Tania de Jong AM, shares more about psychedelic-assisted psychotherapies and their potential for healing mental illness.
TGA says NO again to psychedelic-assisted therapies
Mind Medicine Australia, December 15, 2021
Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy.
MDMA and psilocybin could be removed from the TGA’s list of prohibited medicines
ABC RN Breakfast, December 3, 2021
In this interview MMA Ambassador, Prof David Nutt (UK), speaks about Australia’s drug regulator, the Therapeutic Goods Administration, who is soon set to announce if psilocybin and MDMA should be removed from the prohibited medicines list: “I have to say, one of the things I have been doing a lot here is teaching on Mind Medicine Australia training course which I think is the best course in the world on educating people about how to use psychedelics and how to develop.” (6:19 onwards)
Return trip: Psychedelics have made a comeback in the treatment of mental illness
Wellspring Mag, December 1, 2021
In this interview, Tania de Jong AM, Executive Director at Mind Medicine Australia, discusses the re-emergence of psychedelic-assisted therapy.
A former defence force chief has joined a push to treat post traumatic stress disorder with MDMA
9 News, November 18, 2021
Admiral Chris Barrie AC, a former Defence Force Chief from our board and Veteran Michael Raymond were recently interviewed on 9News. We are advocating for psychedelic medicines which can offer hope to those suffering from severe PTSD and depression.
TGA considering change to classification of psychedelics
ABC News, November 17, 2021
Psychiatrist Dr Stuart Saker says there’s compelling evidence that some psychedelic drugs make effective treatments for people with post-traumatic stress disorder or depression.